Miraculous Medicines

teleport me to a random drug
Minted: - / 5000

1626 Arimoclomol
8776315e3d9b096c0064d199c9e1998baff413ad944822c195fbec77a1ceec96

This DRUG has not been minted yet.
Mint it now with MetaMask!

Send:
ETH
and donate to medical research.
Note: transaction fees shown in metamask are an approximation and are likely to be smaller.

Properties

Chemistry

Arimoclomol (INN; originally codenamed BRX-345, which is a citrate salt formulation of BRX-220) is an experimental drug developed by CytRx Corporation, a biopharmaceutical company based in Los Angeles, California. In 2011 the worldwide rights to arimoclomol were bought by Danish biotech company Orphazyme ApS. The European Medicines Agency (EMA) and U.S. Food & Drug Administration (FDA) granted orphan drug designation to arimoclomol as a potential treatment for Niemann-Pick type C in 2014 and 2015 respectively.

From Wikipedia, the free encyclopedia. License: CC BY-SA.
≪ Previous
1625 Next ≫
1627
Made with on Earth by F. Boffa and T. Calemme
This website does not track you.
Read the contract on Etherscan